SequelSEC

Lantheus Holdings, Inc. LNTH

In Vitro & In Vivo Diagnostic Substances · CIK 0001521036 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.56B
Fiscal year ended 2026-06-30
Operating income
$302.34M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Lantheus Holdings, Inc. (LNTH) reported revenue of $1.56B and net income of $275.30M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Lantheus Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under In Vitro & In Vivo Diagnostic Substances.

Income

Lantheus Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.56B
Cost of revenue$620.30M
Gross profit$936.02M
Operating income$302.34M
Net income$275.30M
Research & development$173.09M
Weighted-average diluted sharesUnavailable
Pretax income$362.98M
Income tax expense$87.67M
Diluted EPSUnavailable
Selling, general & administrative$460.59M
General & administrative$229.96M
Selling & marketing$230.64M

Balance

Lantheus Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$593.30M
Total assets$2.41B
Current assets$1.03B
Total liabilities$1.10B
Current liabilities$335.68M
Total equity incl. NCI$1.31B
Temporary (mezzanine) equityUnavailable
Inventory$57.55M
Accounts receivable$352.89M
Goodwill$239.05M
Long-term debt$570.35M
Accounts payable$48.11M

Cash flow

Lantheus Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$412.80M
Capital expendituresUnavailable
Investing cash flow-$307.02M
Financing cash flow-$207.07M
Net change in cash-$102.25M
Stock-based compensation$78.09M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$88.51M

Derived

Lantheus Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin60.1%
Operating margin19.4%
FCF marginUnavailable
SBC / revenue5.0%
Current ratio3.06x
Revenue YoY growth2.3%
Net margin17.7%
R&D / revenue11.1%
CapEx / revenueUnavailable
Long-term debt / equity0.43x
Effective tax rate24.2%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LNTH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

ACHV AWHL BMRA BZYR CDIO CLDX ICCC IDXX IMDX MYGN NEOG NTLA

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.